EU Distinguishes Medicinal Gas from API
This article was originally published in The Gold Sheet
Is it a gas or is it an active ingredient? The European Commission provides an answer.
You may also be interested in...
Drug makers win one-month reprieve for their nitrosamine risk assessments for new drug products and approved products.
Technologies like head-mounted tablets became critical for method transfers, virtual inspections and more. Cloud-based submissions could be next …
Post-approval change management protocols could go a long way toward smoothing global rollout of analytical method changes, ICH Q12 expert says.